Edges in Network
| Network | GSE5851_egf1520 - GSE5851 - SiGN-BN HC+Bootstrap |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | LGALS3 |
| Upstream (Parents) |
|---|
| (<<) ACTG1 → LGALS3 |
| (<<) ALDOA → LGALS3 |
| (<<) ANXA2 → LGALS3 |
| (<<) CDCP1 → LGALS3 |
| (<<) ELF3 → LGALS3 |
| (<<) ITGB4 → LGALS3 |
| (<<) MST1R → LGALS3 |
| (<<) PRSS3 → LGALS3 |
| (<<) RAC1 → LGALS3 |
| (<<) RDX → LGALS3 |
| (<<) S100P → LGALS3 |
| (<<) TUBA1B → LGALS3 |
| Downstream (Children) |
|---|
| LGALS3 → ACTN4 (>>) |
| LGALS3 → ADORA2B (>>) |
| LGALS3 → ATP10B (>>) |
| LGALS3 → B3GNT3 (>>) |
| LGALS3 → CFL1 (>>) |
| LGALS3 → CKB (>>) |
| LGALS3 → CSTB (>>) |
| LGALS3 → EFHD2 (>>) |
| LGALS3 → ELF4 (>>) |
| LGALS3 → EMP1 (>>) |
| LGALS3 → EPN3 (>>) |
| LGALS3 → INPP5D (>>) |
| LGALS3 → ITGA3 (>>) |
| LGALS3 → ITPR2 (>>) |
| LGALS3 → KCNN4 (>>) |
| LGALS3 → KLF4 (>>) |
| LGALS3 → NBL1 (>>) |
| LGALS3 → OVOL1 (>>) |
| LGALS3 → PLCB4 (>>) |
| LGALS3 → PRKCD (>>) |
| LGALS3 → PRR7 (>>) |
| LGALS3 → RPS6KA1 (>>) |
| LGALS3 → STYK1 (>>) |
| LGALS3 → TPM4 (>>) |
